Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.


Mutations in genes encoding regulators of mTOR, the mammalian target of rapamycin, commonly provide survival signals in cancer cells. Rapamycin and analogs of rapamycin have been used with limited success in clinical trials to target mTOR-dependent survival signals in a variety of human cancers. Suppression of mTOR predominantly causes G1 cell cycle arrest… (More)
DOI: 10.1080/15384101.2015.1046653

2 Figures and Tables


  • Presentations referencing similar topics